37,762,170 Ordinary Shares of Singapore Paincare Holdings Limited are subject to a Lock-Up Agreement Ending on 30-JUL-2023.
July 29, 2023
Share
37,762,170 Ordinary Shares of Singapore Paincare Holdings Limited are subject to a Lock-Up Agreement Ending on 30-JUL-2023. These Ordinary Shares will be under lockup for 1097 days starting from 28-JUL-2020 to 30-JUL-2023.
Details:
Executive Directors, the SPCH medical practitioners and HCSS who collectively hold an aggregate of 113,286,510 Shares representing 70.09% of the issued and paid-up share capital of Company immediately after the Placement, have each undertaken not to, among others, sell, contract to sell, realise, assign, transfer, pledge, grant any option to, dispose of or enter into any agreement that will directly or indirectly constitute or will be deemed as a disposal of any part of (a) their entire shareholding interests in Company as at the date of Listing for a period of one year commencing from the date of our admission to Catalist (the ?Initial Moratorium Period?), (b) two-thirds of their shareholding interests in Company as at the date of Listing for a period of one year commencing immediately from the expiry of the Initial Moratorium Period (the ?Second Moratorium Period?), and (c) the remaining one-third of their shareholding interests in Company as at the date of Listing for a period of one year commencing immediately from the expiry of the Second Moratorium Period.
Each of the Pre-Placement Investors who collectively hold the Conversion Shares representing 12.67% of the issued and paid-up share capital of our Company immediately after the Placement, have each undertaken not to, among others, sell, contract to sell, realise, assign, transfer, pledge, grant any option to, dispose of or enter into any agreement that will directly or indirectly constitute or will be deemed as a disposal of any part of the profit portion of each of their investment in Company for a period of 12 months
commencing from the date of our admission to Catalist.
Singapore Paincare Holdings Limited is a Singapore-based medical services company engaged in pain care, primary care, and other services. The Company focuses on the treatment of patients suffering from chronic pain, and its pain care services include, among others, minimally invasive procedures, cancer pain treatment, specialized injections, pharmacotherapy, and cognitive behavioral therapy. In addition to pain care treatment, the Company also offers a suite of services including general medical consultation, management of chronic and acute conditions, health screening, and dermatology services. Its pain care conditions include neck pain, lower back pain, spinal stenosis, body pain (fibromyalgia), frozen shoulder, osteoarthritis knee pain, heel pain (plantar fasciitis) treatment and tennis elbow. It provides pain treatment such as platelet rich plasma, myofascial pain injections, nucleoplasty, radio frequency ablation, pulsed radio frequency, spinal cord stimulator and endoscopic.